| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/27/2002 | EP1190257A1 Early detection of flaviviruses using the ns1 glycoprotein |
| 03/27/2002 | EP1190089A2 Methods of treatment using lig 72a and variants thereof |
| 03/27/2002 | EP1190083A2 Dna constructs based on the eif4a gene promoter |
| 03/27/2002 | EP1190074A1 Recombinant anti-cd40 antibody and uses thereof |
| 03/27/2002 | EP1190070A1 Cyclic amp phosphodiesterase isoforms and methods of use |
| 03/27/2002 | EP1190065A2 Atp binding cassette transporter protein abc1 polypeptides |
| 03/27/2002 | EP1190056A1 Human cytokine receptor |
| 03/27/2002 | EP1190055A2 Human endogenous retrovirus in breast cancer |
| 03/27/2002 | EP1190053A2 Mammalian calcium channels and related probes, cell lines and methods |
| 03/27/2002 | EP1190052A1 16405 receptor, a g-protein coupled receptor |
| 03/27/2002 | EP1190051A2 Human transport proteins |
| 03/27/2002 | EP1190050A2 Human transcriptional regulator proteins |
| 03/27/2002 | EP1190048A2 Novel candida albicans genes and proteins coded by said genes |
| 03/27/2002 | EP1189947A1 Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines |
| 03/27/2002 | EP1189937A1 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
| 03/27/2002 | EP1189935A1 Extraction of integral membrane proteins |
| 03/27/2002 | EP1189934A2 Oligomeric chaperone proteins |
| 03/27/2002 | EP1189931A2 Peptide compounds that bind her2 |
| 03/27/2002 | EP1189917A1 48 human secreted proteins |
| 03/27/2002 | EP1189631A1 Neurodegenerative disorder related gene |
| 03/27/2002 | EP1189627A1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies |
| 03/27/2002 | EP1077068B1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 03/27/2002 | EP0831906B1 Treatment of t cell mediated autoimmune disorders |
| 03/27/2002 | EP0773999B1 Or-1 an orphan receptor belonging to the nuclear receptor family |
| 03/27/2002 | EP0733123B1 Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
| 03/27/2002 | EP0712442B1 Vaccine compositions |
| 03/27/2002 | CN1342266A Method and kit for extracting prion protein |
| 03/27/2002 | CN1342204A Methods for producing polypeptides in fungal cells |
| 03/27/2002 | CN1342202A Soluble receptor BR43X2 and methods for using them for therapy |
| 03/27/2002 | CN1342197A 蛋白质 Protein |
| 03/27/2002 | CN1341751A Method for catalyzing sequential enzyme reaction by using fusion protein |
| 03/26/2002 | US6362319 Glial cell line-derived neurotrophic factor |
| 03/26/2002 | US6362316 Human metabotropic glutamate receptor subtype mGluR6 protein |
| 03/26/2002 | US6362007 For diagnosis and therapy of systemic lupus erythematosus and related diseases, and diseases in which epstein-barr virus has been implicated |
| 03/26/2002 | US6362001 Establishing a culture of drosophila cells; transfecting with expressible class 1 mhc heavy chain gene linked to promoter; transfecting with an expressible .beta.-2 microglobulin gene and with assisting molecule gene, mixing with peptide |
| 03/26/2002 | US6361998 Culturing an initial population containing erythroid precursors in a serum free defined medium essentially free of fatty acids and hydrocortisone comprising serum albumin, insulin, transferrin, il-3, scf, sa and epo and recovering |
| 03/26/2002 | US6361986 For fermentation using corynebacteria in which the accda gene is amplified |
| 03/26/2002 | US6361977 Methods of using multivariant IL-3 hematopoiesis fusion protein |
| 03/26/2002 | US6361974 Exonuclease-mediated nucleic acid reassembly in directed evolution |
| 03/26/2002 | US6361970 A polypeptide encoding an isoleucyl trna synthetase; therapy and screening antibiotic compounds |
| 03/26/2002 | US6361969 An expression vector containing a dna sequence encoding a thioredoxin and a heterologous protein; for proper folding of heterologous proteins expressed in transformed cells |
| 03/26/2002 | US6361967 Axor10, a g-protein coupled receptor |
| 03/26/2002 | US6361966 Screening escherichia mutant cells resistant to over-expression toxicity by culturing the transformed cells with an expression vector, induce expression for a toxic effect and select viable cells |
| 03/26/2002 | US6361946 A bone marrow modulating method in mammals by adminstering a polypeptide that binds to at least one endothelial cell surface receptor to modulates myelopoiesis |
| 03/26/2002 | US6361779 Transferrin receptor genes |
| 03/26/2002 | US6361778 Carboxyl terminal of papillomavirus L1 region is not required for formation of virus-like particles |
| 03/26/2002 | CA2232727C Novel variants of green fluorescent protein, gfp |
| 03/26/2002 | CA2180570C Isolated p27 protein and its encoding nucleic acid molecules |
| 03/26/2002 | CA2176834C Process for protein production in plants |
| 03/26/2002 | CA2144514C Morphogen-induced liver regeneration |
| 03/26/2002 | CA2137551C A novel endothelial cell molecule mediating lymphocyte binding in man |
| 03/26/2002 | CA1341351C Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
| 03/21/2002 | WO2002023202A2 Method to identify antibody targets based on mass spectrometry (maldi-tof) |
| 03/21/2002 | WO2002022871A2 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | WO2002022851A2 Novel tumor-associated marker |
| 03/21/2002 | WO2002022848A2 Compositions comprising mixtures of human cytokines and methods of producing the same |
| 03/21/2002 | WO2002022832A1 A cell line expressing mutated human tissue - type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein |
| 03/21/2002 | WO2002022802A1 Novel compounds |
| 03/21/2002 | WO2002022786A1 Method and cell composition for screening compounds for anti-inflammatory activity |
| 03/21/2002 | WO2002022782A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 03/21/2002 | WO2002022776A2 Human coagulation factor vii variants |
| 03/21/2002 | WO2002022684A2 Transporters and ion channels |
| 03/21/2002 | WO2002022682A1 Interferon-alpha induced gene |
| 03/21/2002 | WO2002022680A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 03/21/2002 | WO2002022678A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/21/2002 | WO2002022667A2 Twin-arginine translocation in bacillus |
| 03/21/2002 | WO2002022631A2 Regulation of human pyroglutamyl peptidase-like enzyme |
| 03/21/2002 | WO2002021996A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | WO2001098324A8 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 03/21/2002 | WO2001072841A3 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/21/2002 | WO2001072840A3 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/21/2002 | WO2001068861A3 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IgE ANTIBODY AND USES THEREOF |
| 03/21/2002 | WO2001068859A3 Il-17 receptor like molecules and uses thereof |
| 03/21/2002 | WO2001064837A3 β NETRIN AND USES THEREOF |
| 03/21/2002 | WO2001064715A3 Memno peptides, a process for their preparation and their use |
| 03/21/2002 | WO2001062905A3 Integrin antagonists |
| 03/21/2002 | WO2001055411A3 Human sulfatases |
| 03/21/2002 | WO2001051510A3 G-csf conjugates |
| 03/21/2002 | WO2001037779A3 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 03/21/2002 | US20020035734 Binding protein for use in the treatment of neutropenia, infections and cancer |
| 03/21/2002 | US20020035240 Novel mammalian cell cycle protein |
| 03/21/2002 | US20020035063 Derivatives of laspartomycin and preparation and use thereof |
| 03/21/2002 | US20020034789 Isolated proteins containing portions of fapalpha and other proteins |
| 03/21/2002 | US20020034787 Nucleotide sequences coding polypeptides for use in treatment of wounds, burns, ulcers, nervous system disorders and tumors |
| 03/21/2002 | US20020034786 Nucleotide sequences coding G protein coupled receptor; for use in the diagnosis and treatment of defects in signal transduction |
| 03/21/2002 | US20020034778 Peptide; for use in drug screening; for use as a diagnostic tool; for use in the treatment of nervous system disorders |
| 03/21/2002 | US20020034773 Diagnosis cell proliferation defects; obtain sample, detect preferential protein, measure concentration, compare to control, an increase in preferential protein concentration indicates tumors |
| 03/21/2002 | US20020034743 Nucleotide sequences coding protein for use in the detection, diagnosis, prevention and treatment of human cancers |
| 03/21/2002 | US20020034559 E. coli extract for protein synthesis |
| 03/21/2002 | US20020034513 MHC complexes and uses thereof |
| 03/21/2002 | US20020034510 Genetic engineered protein; antiischemic agents |
| 03/21/2002 | US20020034509 Methods and compositions for ameliorating the symptoms of sepsis |
| 03/21/2002 | CA2422828A1 Novel tumor-associated marker |
| 03/21/2002 | CA2422426A1 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | CA2422278A1 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | CA2422152A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/21/2002 | CA2422080A1 Method to identify therapeutic antibody targets associated with a therapeutic response |
| 03/21/2002 | CA2422060A1 Compositions comprising mixtures of human cytokines and methods of producing the same |
| 03/21/2002 | CA2421952A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 03/21/2002 | CA2421303A1 Novel compounds |